Wound Treatments in Italy Report Offers a Comprehensive Guide to the Size and Shape of the Market at a National Level

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c83537) has announced the addition of “Wound Treatments in Italy” to their offering.

Our Wound Treatments in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the wound treatments industry
• Identify growth sectors and factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

EXECUTIVE SUMMARY

Modest Growth in 2006

Sales of OTC healthcare delivered a rather modest performance in 2006, growing by less than 2% in current value terms. Declines in sectors such as cough, cold and allergy remedies, digestive remedies and NRT smoking cessation aids undermined market growth. By contrast, vitamins and dietary supplements continued to perform well, contributing to driving up value sales of the entire industry. The sector benefited from increasing demand for supplementary nutrition products. Positive results were also recorded by wound treatments and eye care, which gained from manufacturers’ innovation activities. The child-specific OTC healthcare sector also delivered a positive performance.

Self-medication Ever More Important

In 2006, one of the key trends in Italy was an increase in self-medication within several sectors, like cough, cold and allergy remedies and vitamins and dietary supplements. There are a number of reasons for this trend. A key role is played by the ageing of Italian population, which is increasing pressure on the national health system, leading the government to promote self-medication for some age-related problems. A further important role is played by the increasing intensity of urban life, which is leading to a growing focus on health, favouring self medication, as this enables people to save time by not seeing a doctor. The greater quantity of information that is available through the Internet and mass media represents an additional reason for this development.

Best Performer Whitehall Italia Gains Second Position in 2006

The Italian OTC market continued to be led by Bayer in 2006, with a 10% value share, despite a slight decline over the previous year. Bayer is particularly strong within analgesics, where it operates with its well-known Aspirina brand, and within vitamins and dietary supplements, with its Supradyn brand. Supported by the popularity of well-known brands such as Polase and Centrum, Whitehall Italia increased its value share in 2006, recording the best performance and taking second place in the rankings, at the expense of ACRAF-Gruppo Angelini. Angelini remains strong in analgesics, where it leads with its Tachipirina brand.

Supermarkets To Challenge Pharmacy Monopoly

The chemists/pharmacies channel maintained its near monopoly across all OTC healthcare sectors in Italy in 2006, despite the government allowing the sale of OTC remedies in non-pharmacy outlets, like supermarkets and hypermarkets. The progressive deregulation of the pharmacy market will reshape the structure of the supply chain in the near future. Supermarkets, hypermarkets and convenience stores will increasingly gain share within OTC healthcare, increasing competition within the non-prescription medicines market in Italy and contributing to a decline in unit prices.

Contents:

OTC Healthcare In Italy

Local Company Profiles - Italy

A Menarini Industrie Farmaceutiche Riunite SRL
Aziende Chimiche Riunite Angelini Francesco Acraf SpA
Bracco SpA
Chiesi Farmaceutici SpA
Perfetti Van Melle SpA
Recordati Industria Chimica E Farmaceutica SpA
Sanofi-aventis SpA
Sigma-tau Industrie Farmaceutiche Riunite SpA
Strategic Direction
Zambon Italia SpA

Wound Treatments In Italy

For more information visit http://www.researchandmarkets.com/reports/c83537

Source: Euromonitor International